News

SINGAPORE: Regulatory Fee Revision for Health Products – January, 2022

SINGAPORE: Regulatory Fee Revision for Health Products – January, 2022

  • 2022-01-26 10:55:53

The Health Sciences Authority (HSA) has published an update on the Regulatory Fees for Health Products. This is to ensure that the evaluated products meet the required standards of quality safety and efficacy. It is also necessary to recover part of the costs for the services rendered to businesses.

More
CHINA: Medical Device Clinical Trial Data Submission Requirements for Registration Review Guidelines-No. 91 in 2021 – January, 2022

CHINA: Medical Device Clinical Trial Data Submission Requirements for Registration Review Guidelines-No. 91 in 2021 – January, 2022

  • 2022-01-26 08:31:11

Clinical trial data is one of the important supporting documents for evaluating the safety and effectiveness of medical devices. Standardizing the collection, sorting, analysis, and submission of medical device clinical trial data will not only improve the quality of clinical trial implementation and management but also assist the regulatory agency to understand and review the development of clinical trials quickly and efficiently.

More
AUSTRALIA: FAQs for Software-Based Medical Devices – January, 2022

AUSTRALIA: FAQs for Software-Based Medical Devices – January, 2022

  • 2022-01-26 08:15:53

TGA has already implemented reforms to the regulation of software-based medical devices from 25 February 2021. Under the new regulation, some software may be excluded from the TGA regulations, or although still regulated by TGA they may be exempted from the need to include the product in the ARTG. In the following, we gathered some FAQs and have summarised TGA’s article to help you have an insight on what is required to operate legally in Australia.

More
AUSTRALIA: Essential Principles - Consent for Noncompliance – January, 2022

AUSTRALIA: Essential Principles - Consent for Noncompliance – January, 2022

  • 2022-01-26 04:00:20

Despite it being a criminal offense to import, supply or export medical devices that do not meet the EPSP, there may be extenuating circumstances preventing compliance to one or more parts of an Essential Principle for a limited period of time. TGA Australia grants exemption in certain situations. Here we gather some FAQs related to the application of the consent for non-compliance of the medical devices and summarize this article in order to help you understand what you need to know for the condition and application.

More
QT WEBINAR: New CER Requirements in China

QT WEBINAR: New CER Requirements in China

  • 2021-12-27 06:33:04

Qualtech Consulting would like to invite you to our free online Webinar on the subject of "New CER Requirements in China". Our event is scheduled to be held on January 21st (Friday), 2022.

More